-
2
-
-
0016685516
-
Potentiation of levodopa effect by intravenous l-prolyl-l-leucyl-glycine amide in man
-
Barbeau A. Potentiation of levodopa effect by intravenous l-prolyl-l-leucyl-glycine amide in man. Lancet 2 (1975) 683-684
-
(1975)
Lancet
, vol.2
, pp. 683-684
-
-
Barbeau, A.1
-
3
-
-
0018213664
-
Peptides in Parkinson's disease
-
Barbeau A. Peptides in Parkinson's disease. Adv Exp Med Biol 113 (1978) 101-110
-
(1978)
Adv Exp Med Biol
, vol.113
, pp. 101-110
-
-
Barbeau, A.1
-
4
-
-
0021040859
-
3H]apomorphine binding sites
-
3H]apomorphine binding sites. Gen Pharmacol 14 (1983) 609-614
-
(1983)
Gen Pharmacol
, vol.14
, pp. 609-614
-
-
Bhargava, H.N.1
-
5
-
-
0035028512
-
Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence
-
Carlsson A., Waters N., Holm-Waters S., Tedroff J., Nilsson M., and Carlsson M.L. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 41 (2001) 237-260
-
(2001)
Annu Rev Pharmacol Toxicol
, vol.41
, pp. 237-260
-
-
Carlsson, A.1
Waters, N.2
Holm-Waters, S.3
Tedroff, J.4
Nilsson, M.5
Carlsson, M.L.6
-
6
-
-
0021799812
-
Active and inactive l-prolyl-l-leucyl glycinamide synthetic analogs in rat models of levodopa-treated Parkinson's disease
-
Case T.C., Snider S.R., Hruby V.J., and Rockway T. Active and inactive l-prolyl-l-leucyl glycinamide synthetic analogs in rat models of levodopa-treated Parkinson's disease. Life Sci 36 (1985) 2531-2537
-
(1985)
Life Sci
, vol.36
, pp. 2531-2537
-
-
Case, T.C.1
Snider, S.R.2
Hruby, V.J.3
Rockway, T.4
-
7
-
-
34548674969
-
-
Society for Neuroscience, San Diego, CA p. 113.12
-
Castellano J.M., Paladino P., Skoblenick K.J., Dyck B.A., Johnson R.L., and Mishra R.K. Increased expression of protein kinase B by the endogenous brain peptide l-Pro-l-Leu-glycinamide vol. 34 (2004), Society for Neuroscience, San Diego, CA p. 113.12
-
(2004)
Increased expression of protein kinase B by the endogenous brain peptide l-Pro-l-Leu-glycinamide
, vol.34
-
-
Castellano, J.M.1
Paladino, P.2
Skoblenick, K.J.3
Dyck, B.A.4
Johnson, R.L.5
Mishra, R.K.6
-
8
-
-
0019798052
-
Effect of l-prolyl-l-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine/neuroleptic receptor bindings
-
Chiu S., Paulose C.S., and Mishra R.K. Effect of l-prolyl-l-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine/neuroleptic receptor bindings. Peptides 2 (1981) 105-111
-
(1981)
Peptides
, vol.2
, pp. 105-111
-
-
Chiu, S.1
Paulose, C.S.2
Mishra, R.K.3
-
9
-
-
0021024260
-
Are the pharmacological effects of l-prolyl-l-leucyl-glycinamide (PLG) mediated through specific receptor mechanisms?
-
Chiu S., Wong Y.W., Wan Y.P., Chiu P., and Mishra R.K. Are the pharmacological effects of l-prolyl-l-leucyl-glycinamide (PLG) mediated through specific receptor mechanisms?. Prog Neuropsychopharmacol Biol Psychiatry 7 (1983) 739-742
-
(1983)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.7
, pp. 739-742
-
-
Chiu, S.1
Wong, Y.W.2
Wan, Y.P.3
Chiu, P.4
Mishra, R.K.5
-
10
-
-
0036490942
-
Allosteric binding sites on cell-surface receptors: novel targets for drug discovery
-
Christopoulos A. Allosteric binding sites on cell-surface receptors: novel targets for drug discovery. Nat Rev Drug Discov 1 (2002) 198-210
-
(2002)
Nat Rev Drug Discov
, vol.1
, pp. 198-210
-
-
Christopoulos, A.1
-
11
-
-
0036258990
-
G protein-coupled receptor allosterism and complexing
-
Christopoulos A., and Kenakin T. G protein-coupled receptor allosterism and complexing. Pharmacol Rev 54 (2002) 323-374
-
(2002)
Pharmacol Rev
, vol.54
, pp. 323-374
-
-
Christopoulos, A.1
Kenakin, T.2
-
12
-
-
0014208039
-
Aromatic amino acids and modification of parkinsonism
-
Cotzias G.C., Van Woert M.H., and Schiffer L.M. Aromatic amino acids and modification of parkinsonism. N Engl J Med 276 (1967) 374-379
-
(1967)
N Engl J Med
, vol.276
, pp. 374-379
-
-
Cotzias, G.C.1
Van Woert, M.H.2
Schiffer, L.M.3
-
13
-
-
0036283426
-
Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway
-
Deumens R., Blokland A., and Prickaerts J. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 175 (2002) 303-317
-
(2002)
Exp Neurol
, vol.175
, pp. 303-317
-
-
Deumens, R.1
Blokland, A.2
Prickaerts, J.3
-
14
-
-
0037468419
-
Synthesis and dopamine receptor modulating activity of 3-substituted gamma-lactam peptidomimetics of l-prolyl-l-leucyl-glycinamide
-
Dolbeare K., Pontoriero G.F., Gupta S.K., Mishra R.K., and Johnson R.L. Synthesis and dopamine receptor modulating activity of 3-substituted gamma-lactam peptidomimetics of l-prolyl-l-leucyl-glycinamide. J Med Chem 46 (2003) 727-733
-
(2003)
J Med Chem
, vol.46
, pp. 727-733
-
-
Dolbeare, K.1
Pontoriero, G.F.2
Gupta, S.K.3
Mishra, R.K.4
Johnson, R.L.5
-
15
-
-
0028141261
-
Prevention and reversal of dopamine receptor supersensitivity by cyclo(leucyl-glycyl) (CLG): biphasic dose-response curves
-
Drucker G.E., Ritzmann R.F., Wichlinski L.J., Engh K., Gordon J.H., and Fields J.Z. Prevention and reversal of dopamine receptor supersensitivity by cyclo(leucyl-glycyl) (CLG): biphasic dose-response curves. Pharmacol Biochem Behav 47 (1994) 141-145
-
(1994)
Pharmacol Biochem Behav
, vol.47
, pp. 141-145
-
-
Drucker, G.E.1
Ritzmann, R.F.2
Wichlinski, L.J.3
Engh, K.4
Gordon, J.H.5
Fields, J.Z.6
-
17
-
-
0016260920
-
Letter: lithium and M.R.I.H. in tardive dyskinesia
-
Ehrensing R.H. Letter: lithium and M.R.I.H. in tardive dyskinesia. Lancet 2 (1974) 1459-1460
-
(1974)
Lancet
, vol.2
, pp. 1459-1460
-
-
Ehrensing, R.H.1
-
18
-
-
0015996803
-
Melanocyte-stimulating hormone-release inhibiting hormone as a antidepressant. A pilot study
-
Ehrensing R.H., and Kastin A.J. Melanocyte-stimulating hormone-release inhibiting hormone as a antidepressant. A pilot study. Arch Gen Psychiatry 30 (1974) 63-65
-
(1974)
Arch Gen Psychiatry
, vol.30
, pp. 63-65
-
-
Ehrensing, R.H.1
Kastin, A.J.2
-
19
-
-
0017347555
-
Melanocyte-stimulating-hormone release-inhibiting factor-I and tardive dyskinesia
-
Ehrensing R.H., Kastin A.J., Larsons P.F., and Bishop G.A. Melanocyte-stimulating-hormone release-inhibiting factor-I and tardive dyskinesia. Dis Nerv Syst 38 (1977) 303-307
-
(1977)
Dis Nerv Syst
, vol.38
, pp. 303-307
-
-
Ehrensing, R.H.1
Kastin, A.J.2
Larsons, P.F.3
Bishop, G.A.4
-
20
-
-
0027980482
-
Improvement in major depression after low subcutaneous doses of MIF-1
-
Ehrensing R.H., Kastin A.J., Wurzlow G.F., Michell G.F., and Mebane A.H. Improvement in major depression after low subcutaneous doses of MIF-1. J Affect Disord 31 (1994) 227-233
-
(1994)
J Affect Disord
, vol.31
, pp. 227-233
-
-
Ehrensing, R.H.1
Kastin, A.J.2
Wurzlow, G.F.3
Michell, G.F.4
Mebane, A.H.5
-
21
-
-
0033594361
-
Synthesis and dopamine receptor modulating activity of novel peptidomimetics of l-prolyl-l-leucyl-glycinamide featuring alpha,alpha-disubstituted amino acids
-
Evans M.C., Pradhan A., Venkatraman S., Ojala W.H., Gleason W.B., Mishra R.K., et al. Synthesis and dopamine receptor modulating activity of novel peptidomimetics of l-prolyl-l-leucyl-glycinamide featuring alpha,alpha-disubstituted amino acids. J Med Chem 42 (1999) 1441-1447
-
(1999)
J Med Chem
, vol.42
, pp. 1441-1447
-
-
Evans, M.C.1
Pradhan, A.2
Venkatraman, S.3
Ojala, W.H.4
Gleason, W.B.5
Mishra, R.K.6
-
22
-
-
0020044368
-
Oral dyskinesia in rats following brain lesions and neuroleptic drug administration
-
Gunne L.M., Growdon J., and Glaeser B. Oral dyskinesia in rats following brain lesions and neuroleptic drug administration. Psychopharmacology (Berl) 77 (1982) 134-139
-
(1982)
Psychopharmacology (Berl)
, vol.77
, pp. 134-139
-
-
Gunne, L.M.1
Growdon, J.2
Glaeser, B.3
-
23
-
-
0022534215
-
Acute administration of MIF-1 or Tyr-MIF-1 inhibits haloperidol-induced catalepsy in rats
-
Hara C., and Kastin A.J. Acute administration of MIF-1 or Tyr-MIF-1 inhibits haloperidol-induced catalepsy in rats. Pharmacol Biochem Behav 24 (1986) 1785-1787
-
(1986)
Pharmacol Biochem Behav
, vol.24
, pp. 1785-1787
-
-
Hara, C.1
Kastin, A.J.2
-
24
-
-
0022967724
-
Biphasic effects of MIF-1 and Tyr-MIF-1 on apomorphine-induced stereotypy in rats
-
Hara C., and Kastin A.J. Biphasic effects of MIF-1 and Tyr-MIF-1 on apomorphine-induced stereotypy in rats. Pharmacol Biochem Behav 25 (1986) 757-761
-
(1986)
Pharmacol Biochem Behav
, vol.25
, pp. 757-761
-
-
Hara, C.1
Kastin, A.J.2
-
25
-
-
0031981787
-
Mixture in the distribution of haloperidol-induced oral dyskinesias in the rat supports an animal model of tardive dyskinesia
-
Hashimoto T., Ross D.E., Gao X.M., Medoff D.R., and Tamminga C.A. Mixture in the distribution of haloperidol-induced oral dyskinesias in the rat supports an animal model of tardive dyskinesia. Psychopharmacology (Berl) 137 (1998) 107-112
-
(1998)
Psychopharmacology (Berl)
, vol.137
, pp. 107-112
-
-
Hashimoto, T.1
Ross, D.E.2
Gao, X.M.3
Medoff, D.R.4
Tamminga, C.A.5
-
26
-
-
0027449341
-
Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats
-
Hudson J.L., van Horne C.G., Stromberg I., Brock S., Clayton J., Masserano J., et al. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res 626 (1993) 167-174
-
(1993)
Brain Res
, vol.626
, pp. 167-174
-
-
Hudson, J.L.1
van Horne, C.G.2
Stromberg, I.3
Brock, S.4
Clayton, J.5
Masserano, J.6
-
27
-
-
0033452716
-
Effects of chronic haloperidol and clozapine on vacuous chewing and dopamine-mediated jaw movements in rats: evaluation of a revised animal model of tardive dyskinesia
-
Ikeda H., Adachi K., Hasegawa M., Sato M., Hirose N., Koshikawa N., et al. Effects of chronic haloperidol and clozapine on vacuous chewing and dopamine-mediated jaw movements in rats: evaluation of a revised animal model of tardive dyskinesia. J Neural Transm 106 (1999) 1205-1216
-
(1999)
J Neural Transm
, vol.106
, pp. 1205-1216
-
-
Ikeda, H.1
Adachi, K.2
Hasegawa, M.3
Sato, M.4
Hirose, N.5
Koshikawa, N.6
-
28
-
-
0022874763
-
2 analogues possessing cyclic amino acid residues at the C-terminal position
-
2 analogues possessing cyclic amino acid residues at the C-terminal position. J Med Chem 29 (1986) 2100-2104
-
(1986)
J Med Chem
, vol.29
, pp. 2100-2104
-
-
Johnson, R.L.1
Rajakumar, G.2
Mishra, R.K.3
-
29
-
-
0022472378
-
2 analogues modified at the prolyl residue and evaluation of their effects on the receptor binding activity of the central dopamine receptor agonist, ADTN
-
2 analogues modified at the prolyl residue and evaluation of their effects on the receptor binding activity of the central dopamine receptor agonist, ADTN. J Med Chem 29 (1986) 2104-2107
-
(1986)
J Med Chem
, vol.29
, pp. 2104-2107
-
-
Johnson, R.L.1
Rajakumar, G.2
Yu, K.L.3
Mishra, R.K.4
-
30
-
-
0015499661
-
Preliminary clinical studies with l-prolyl-l-leucyl-glycine amide in Parkinson's disease
-
Kastin A.J., and Barbeau A. Preliminary clinical studies with l-prolyl-l-leucyl-glycine amide in Parkinson's disease. Can Med Assoc J 107 (1972) 1079-1081
-
(1972)
Can Med Assoc J
, vol.107
, pp. 1079-1081
-
-
Kastin, A.J.1
Barbeau, A.2
-
31
-
-
0018168469
-
Potentiation of apomorphine action in rats by l-prolyl-l-leucyl-glycine amide
-
Kostrzewa R.M., Kastin A.J., and Sobrian S.K. Potentiation of apomorphine action in rats by l-prolyl-l-leucyl-glycine amide. Pharmacol Biochem Behav 9 (1978) 375-378
-
(1978)
Pharmacol Biochem Behav
, vol.9
, pp. 375-378
-
-
Kostrzewa, R.M.1
Kastin, A.J.2
Sobrian, S.K.3
-
36
-
-
0023543618
-
Pharmacological activities of the MIF-1 analogues Pro-Leu-Gly, Tyr-Pro-Leu-Gly and peptide
-
Mycroft F.J., Bhargava H.N., and Wei E.T. Pharmacological activities of the MIF-1 analogues Pro-Leu-Gly, Tyr-Pro-Leu-Gly and peptide. Peptides 8 (1987) 1051-1055
-
(1987)
Peptides
, vol.8
, pp. 1051-1055
-
-
Mycroft, F.J.1
Bhargava, H.N.2
Wei, E.T.3
-
37
-
-
0030597196
-
Modulation of dopaminergic neurotransmission in the 6-hydroxydopamine lesioned rotational model by peptidomimetic analogues of l-prolyl-l-leucyl-glycinamide
-
Ott M.C., Mishra R.K., and Johnson R.L. Modulation of dopaminergic neurotransmission in the 6-hydroxydopamine lesioned rotational model by peptidomimetic analogues of l-prolyl-l-leucyl-glycinamide. Brain Res 737 (1996) 287-291
-
(1996)
Brain Res
, vol.737
, pp. 287-291
-
-
Ott, M.C.1
Mishra, R.K.2
Johnson, R.L.3
-
38
-
-
0023402612
-
Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of l-prolyl-l-leucyl-glycinamide (PLG)
-
Rajakumar G., Naas F., Johnson R.L., Chiu S., Yu K.L., and Mishra R.K. Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of l-prolyl-l-leucyl-glycinamide (PLG). Peptides 8 (1987) 855-861
-
(1987)
Peptides
, vol.8
, pp. 855-861
-
-
Rajakumar, G.1
Naas, F.2
Johnson, R.L.3
Chiu, S.4
Yu, K.L.5
Mishra, R.K.6
-
40
-
-
7244247021
-
Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia
-
Rogoza R.M., Fairfax D.F., Henry P., Marandi S., Khan R.F., Gupta S.K., et al. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia. Synapse 54 (2004) 156
-
(2004)
Synapse
, vol.54
, pp. 156
-
-
Rogoza, R.M.1
Fairfax, D.F.2
Henry, P.3
Marandi, S.4
Khan, R.F.5
Gupta, S.K.6
-
41
-
-
0034087775
-
The current status of tardive dyskinesia
-
Sachdev P.S. The current status of tardive dyskinesia. Aust N Z J Psychiatry 34 (2000) 355-369
-
(2000)
Aust N Z J Psychiatry
, vol.34
, pp. 355-369
-
-
Sachdev, P.S.1
-
43
-
-
25444442033
-
Novel oral drug administration in an animal model of neuroleptic therapy
-
Schleimer S.B., Johnston G.A., and Henderson J.M. Novel oral drug administration in an animal model of neuroleptic therapy. J Neurosci Methods 146 (2005) 159-164
-
(2005)
J Neurosci Methods
, vol.146
, pp. 159-164
-
-
Schleimer, S.B.1
Johnston, G.A.2
Henderson, J.M.3
-
45
-
-
0037303584
-
Pro-Leu-glycinamide and its peptidomimetic, PAOPA, attenuate haloperidol induced vacuous chewing movements in rat: a model of human tardive dyskinesia
-
Sharma S., Paladino P., Gabriele J., Saeedi H., Henry P., Chang M., et al. Pro-Leu-glycinamide and its peptidomimetic, PAOPA, attenuate haloperidol induced vacuous chewing movements in rat: a model of human tardive dyskinesia. Peptides 24 (2003) 313-319
-
(2003)
Peptides
, vol.24
, pp. 313-319
-
-
Sharma, S.1
Paladino, P.2
Gabriele, J.3
Saeedi, H.4
Henry, P.5
Chang, M.6
-
46
-
-
0020075357
-
The effects of prolyl-leucyl-glycine amide on drug-induced rotation in lesioned rats
-
Smith J.R., and Morgan M. The effects of prolyl-leucyl-glycine amide on drug-induced rotation in lesioned rats. Gen Pharmacol 13 (1982) 203-207
-
(1982)
Gen Pharmacol
, vol.13
, pp. 203-207
-
-
Smith, J.R.1
Morgan, M.2
-
48
-
-
0032078429
-
Study on the suitability of a rat model for tardive dyskinesia and the preventive effects of various drugs
-
Takeuchi H., Ishigooka J., Kobayashi K., Watanabe S., and Miura S. Study on the suitability of a rat model for tardive dyskinesia and the preventive effects of various drugs. Prog Neuropsychopharmacol Biol Psychiatry 22 (1998) 679-691
-
(1998)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.22
, pp. 679-691
-
-
Takeuchi, H.1
Ishigooka, J.2
Kobayashi, K.3
Watanabe, S.4
Miura, S.5
-
49
-
-
13444283624
-
Continuous but not intermittent olanzapine infusion induces vacuous chewing movements in rats
-
Turrone P., Remington G., Kapur S., and Nobrega J.N. Continuous but not intermittent olanzapine infusion induces vacuous chewing movements in rats. Biol Psychiatry 57 (2005) 406-411
-
(2005)
Biol Psychiatry
, vol.57
, pp. 406-411
-
-
Turrone, P.1
Remington, G.2
Kapur, S.3
Nobrega, J.N.4
-
50
-
-
0036106055
-
The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy?
-
Turrone P., Remington G., and Nobrega J.N. The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy?. Neurosci Biobehav Rev 26 (2002) 361-380
-
(2002)
Neurosci Biobehav Rev
, vol.26
, pp. 361-380
-
-
Turrone, P.1
Remington, G.2
Nobrega, J.N.3
-
51
-
-
27744575172
-
Modulation of agonist binding to human dopamine receptor subtypes by l-prolyl-l-leucyl-glycinamide and a peptidomimetic analog
-
Verma V., Mann A., Costain W., Pontoriero G., Castellano J.M., Skoblenick K., et al. Modulation of agonist binding to human dopamine receptor subtypes by l-prolyl-l-leucyl-glycinamide and a peptidomimetic analog. J Pharmacol Exp Ther 315 (2005) 1228-1236
-
(2005)
J Pharmacol Exp Ther
, vol.315
, pp. 1228-1236
-
-
Verma, V.1
Mann, A.2
Costain, W.3
Pontoriero, G.4
Castellano, J.M.5
Skoblenick, K.6
-
52
-
-
0036159250
-
Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder
-
Volavka J., Czobor P., Sheitman B., Lindenmayer J.P., Citrome L., McEvoy J.P., et al. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Am J Psychiatry 159 (2002) 255-262
-
(2002)
Am J Psychiatry
, vol.159
, pp. 255-262
-
-
Volavka, J.1
Czobor, P.2
Sheitman, B.3
Lindenmayer, J.P.4
Citrome, L.5
McEvoy, J.P.6
|